76 results
8-K
EX-10.1
oglstrsmo
10 Jan 22
NeuBase Therapeutics Appoints Todd P. Branning Chief Financial Officer
4:06pm
8-K
EX-10.1
b3h9d7bm
1 Oct 21
Departure of Directors or Certain Officers
4:17pm
8-K
EX-10.1
a6nsgzhsx7pnctpqvg
25 May 21
NeuBase Therapeutics Appoints Dr. Kia Motesharei Chief Business and Strategy Officer
9:00am
8-K
EX-10.1
oi227l2c
20 May 21
NeuBase Therapeutics Appoints Dr. Sandra Rojas-Caro Chief Medical Officer
9:00am
8-K
EX-99.1
him0nj bnf48
16 Dec 20
Regulation FD Disclosure
9:00am
8-K
EX-10.1
mlk8f56c5nhqy2ho
2 Dec 20
NeuBase Therapeutics Announces Appointment of Curt Bradshaw, Ph.D. as Chief Scientific Officer
9:57am
8-K
EX-10.1
f6om3d93j8up14kgbjl
28 Jul 20
NeuBase Therapeutics Strengthens Senior Management Team with Appointment of Industry Veteran William Mann, Ph.D., MBA as Chief Operating Officer
8:16am
S-8
EX-4.8
1kv0 qz9f9g4lemcccq
16 Aug 19
Registration of securities for employees
5:02pm
8-K/A
EX-10.1
p7h2 i2qzd7k6
17 Jul 19
Unregistered Sales of Equity Securities
5:26pm